RECRUITING

Empathic Communication Skills (ECS) Training

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.

Official Title

Empathic Communication Skills Training to Reduce Lung Cancer Stigma

Quick Facts

Study Start:2023-04-28
Study Completion:2026-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05456841

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report
  2. * Reports a clinic volume of at least 20 new lung cancer patients per month as per self report
  3. * OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report;
  4. * OCP conducts consultations with lung cancer patients, as per self-report;
  5. * OCP sees at least 1 lung cancer patient per week, as per self-report;
  6. * Patient under the care of a participating OCP as per self report;
  7. * English and/or Spanish speaking;
  8. * In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally?
  9. * If English, treat as fluent in English, no additional language questions
  10. * If Spanish, treat as fluent in Spanish, no additional language questions
  11. * If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers
  12. * How well do you speak English? Not at all/ Not well/Well/Very well
  13. * How well do you speak Spanish? Not at all/Not well/Well/Very well
  14. * Is at least 18 years of age as per self report;
  15. * Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;
  16. * Is a former or current smoking as per self report;
  17. * Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report
  1. * Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR.
  2. * None

Contacts and Locations

Study Contact

Smita Banerjee, PhD
CONTACT
646-888-0011
banerjes@mskcc.org
Jamie Ostroff, PhD
CONTACT
646-888-0041
ostroffj@mskcc.org

Principal Investigator

Smita Banerjee, PhD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Providence St. Joseph Health (Data Collection Only)
Irvine, California, 92612
United States
Advocate Health Care Network
Libertyville, Illinois, 60048
United States
University of Kentucky (Data Collection Only)
Lexington, Kentucky, 40536-0093
United States
Munson Healthcare (Data Collection Only)
Traverse City, Michigan, 49684
United States
Hackensack Meridian Health (Data collection only)
Hackensack, New Jersey, 07601
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
United States
Virtua Health (Data Collection Only)
Philadelphia, Pennsylvania, 08060
United States
Chesapeake Regional Healthcare (Data Collection Only)
Chesapeake, Virginia, 23320
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Smita Banerjee, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-28
Study Completion Date2026-08-31

Study Record Updates

Study Start Date2023-04-28
Study Completion Date2026-08-31

Terms related to this study

Keywords Provided by Researchers

  • lung cancer
  • thoracic oncology physician
  • thoracic oncology nurse practitioner
  • thoracic oncology physicians assistant
  • 21-339
  • Memorial Sloan Kettering Cancer Center

Additional Relevant MeSH Terms

  • Lung Cancer